Pellett: Virology - Pathogenesis Flashcards

1
Q

Viruses

Result of infection:

Relationship between viruses and disease

3 other principles of viral infections

A

Most result in asymptomatic (subclinical) infections

Same disease may be caused by a variety of different viruses

Same virus may cause a variety of diseases

  • Local vs. systemic infections
  • Seasonality
  • Various incubation periods: time to disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outcome of infection determined by the interaction of the virus and the host

A
o	Virus strain
o	Route of infection
o	Infectious dose
o	Host immune status
o	Host genetics
o	Virus cytotoxicity
o	Immunopathology
o	Host health
o	Co-infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Routes of Person-to-person transmission (7):

A
Person-to-person transmission: some paths more likely if illness present; others if relatively healthy
	Fecal-oral
	Respiratory
	Animal bite
	Arthropods
	Sexual
	Bloodborne
	Vertically (transplacental, genetic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Incubation periods of:

Influenza
Common cold
Herpes
Rabies
AIDS
A
Influenza: 1-2 days
Common cold: 1-3 days
Herpes: 5-8 days
Rabies: 30- 100 days
AIDS: 1-10 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Latent State:

Cellular:
Organismal:

A

Cellular: no infectious particles produced; can be reactivated to lytic state

Organismal: period between infection and disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Persistent Infection:

Cellular:
Organismal:

A

Cellular: lytic state, equilibrium between cell death and production (but still making virus paticles)

Organismal: continuous inhabitation of the host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Abortive Infection:

A

Abortive Infection: non-productive, not reactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Patterns of Viral Infection:

o Acute:
o Latent:
o Progressive:
o Chronic or Persistent:

A

o Acute: GI viruses
o Latent: HSV (reactivations occur)
o Progressive: HIV or hep C
o Chronic or Persistent: HIV or hep C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Patterns of Viral Infection:

o Failure to clear all evidence of infection:
o Subclinical/asymptomatic:
o Slow:

A

o Failure to clear all evidence of infection: polio and measles
o Subclinical/asymptomatic: ~50% of HSV transmission is during asymptomatic periods
o Slow: long-term persistence prior to onset of disease (HPV and cervical cancer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Genes groups based on contribution to virulence:

Basic Replication Functions:

Immunevasion:

Cell and tissue tropism:

Toxic products:

A

Genes groups based on contribution to virulence:

Basic Replication Functions: viral RNA polymerase

Immunevasion: proteins that downregulate Ag presentation

Cell and tissue tropism: HIV uses CD4 as cellular receptor

Toxic products: rotavirus NSP4 induces diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Disease in immunocompromised infections (2):

A

Opportunistic infections (OI)

De novo vs. prior infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why does viral load matter?

A

The larger the load, the higher the probability of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Viruses and Cancer: generally unintended by-products of niche-management by the virus

HPV:

HTLV-1:

HHV-8:

EBV:

Hep B/Hep C:

A

Viruses and Cancer: generally unintended by-products of niche-management by the virus

HPV and cervical cancer

HTLV-1 and T cell leukemia

HHV-8 and Kaposi’s sarcoma

EBV and Burkitt’s Lymphoma and nasopharyngeal carcinoma

Hep B/Hep C and liver cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Innate immunity (3):

A

Physical barriers: skin, mucosa, respiratory filters

Intracellular defenses: IFN (and other cytokines), PKR, RNase, stress responses, cell-death (apoptosis, necrosis, autophagy)

NK cells, macrophages and neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acquired immunity (2):

Effect of abs against virions:
Effect of abs against viral proteins on cell surfaces:

A

Antibodies and complement

  • Abs against virions: neutralization
  • Abs against viral proteins on cell surfaces: neutralization, inhibition of viral replication, inhibition of virus release, infected cell lysis and clearance, inhibition of cell-cell transmission

T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Viral immune escape

A

ESSENTIALLY EVERY DEFENSE CAN BE BLOCKED OR CIRCUMVENTED BY A VIRUS

17
Q

Manipulation of the immune system:

What type of virus?
Large DNA viruses:
What are host-derived?

A
  • All viruses do it
  • Large DNA viruses dedicate more genes to the task
  • Many viral immunomodulatory genes are host-derived
18
Q

Targets for immune evasion:

Innate vs. Adaptive Responses

A

Innate Defenses:

  • Apoptosis
  • IFN responses
  • PKR pathway (proten kinase RNA-activated pathway)

Adaptive Responses:
- Ag prensetation

19
Q

What is the PKR pathway?
Activated by:
Net result:
What can the virus do?

A

PKR pathway (proten kinase RNA-activated pathway):

Activated by dsRNA, which is uncommon outside of a virus infection and net result is translational arrest (under normal conditions); the virus can employ mechanisms to inhibit this pathway (allowing translation to occur)

20
Q

Diagnostic tests that detect the agent (5):

A
o	Cytology
o	Electron microscopy
o	Direct fluorescent Ab (DFA)
o	Cell culture
o	Nucleic Acids (PCR)
21
Q

Diagnostic tests that Detect Response to the Agent:

A

Serotology (look for Abs against the agent)

22
Q

What must antivirals do?

A

Must selectively inhibit viral functions without damaging the host

23
Q

Targets of antivirals (5):

A

Targets: every step in replication cycle is potential target

Attachment and entry (fusion inhibitors)

Uncoating (ion channel blockers)

Genome replication (polymerase inhibitors)

Protein synthesis/assembly and maturation (protease inhibitors)

Egress and release (neuraminidase inhibitors)

24
Q

Examples:

Fusion inhibitors:

Ion channel blockers:

Polymerase inhibitors:

Protease inhibitors:

Neuraminidase inhibitors:

A

Fusion inhibitors: Enfuvirtide (T-20)

Ion channel blockers: Amantadine, Rimantadine

Polymerase inhibitors: Acyclovir, Zidovudine, Efavirenz

Protease inhibitors: Saquinavir, Ritonavir

Neuraminidase inhibitors: Zanamivir

25
Q

Why are antivirals relatively ineffective clinically as compared to bacterial agents?

A

Many rounds of viral replication has occurred during the incubation period before symptoms develop

26
Q

What is most important to prevent infection

A

vaccination

27
Q

How is acyclovir activated?

A

Acyclovir must be phosphorylated by viral thymidine kinase

28
Q

Key Issues (5):

A
o	Specificity
o	Toxicity
o	Rapid diagnosis
o	Therapeutic threshold
o	Resistance